Profile
ACB ZTS TAK HLN TEVA NBIX
Company Name Aurora Cannabis Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $273.95M $67.90B $47.69B $43.90B $22.86B $14.30B
Employees 1.07K 13.80K 49.28K 24.56K 37.00K 1.80K
CEO Miguel Martin Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Kyle W. Gano
Ratings
ACB ZTS TAK HLN TEVA NBIX
Quant Rating Score 3 3 3 3 1 4
Quant Rating Neutral Neutral Neutral Neutral Strong Sell Buy
Trading
ACB ZTS TAK HLN TEVA NBIX
Last Close $4.87 $148.2 $15.1 $9.81 $19.93 $141.87
High 52 $6.62 $196.48 $15.52 $11.41 $22.77 $153.29
Low 52 $3.46 $144.45 $12.89 $9.01 $12.82 $87.59
Price vs. 52 Week High -26.44 % -24.57 % -2.71 % -14.02 % -12.47 % -7.45 %
Price vs. 52 Week Low 40.75 % 2.6 % 17.15 % 8.88 % 55.46 % 61.97 %
Total Return
ACB ZTS TAK HLN TEVA NBIX
1 Month Return -4.13 % -3.83 % 0.67 % 1.66 % 11.59 % 6.75 %
3 Month Return -16.75 % -9.82 % -0.66 % -9.75 % 17.3 % 14.05 %
6 Month Return 10.43 % -8.1 % 0.6 % -3.35 % 22.05 % 28.1 %
9 Month Return 12.99 % -16.83 % 12.52 % 0.51 % 20.79 % 11.97 %
YTD Return 14.59 % -9.04 % 14.05 % 2.83 % -9.57 % 3.93 %
1 Year Return -16.03 % -22.44 % 2.72 % -6.66 % 8.26 % 16.05 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACB ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 1.26 % 4.36 % 0.02 % - -
Dividend Paid and Capex Coverage Ration (TTM) 0.85 % 1.89 % 2.03 % - 2.78 % 14.7 %
Dividend Per Share (TTM) - 1.93 % 196 % 0.06 % - -
Payout Ratio (TTM) - 32.08 % 226.17 % - - -
Growth
ACB ZTS TAK HLN TEVA NBIX
Asset Growth 1.67 % -5.7 % -9.55 %
Gross Profit Growth 42.71 % 5.97 % 5.47 %
Revenue Growth 27.01 % 7.45 % 4.4 %
Revenue 3 Year -39.26 % 25.02 % 1.52 %
Revenue 5 Year -77.11 % 35.03 % -5.5 %
Revenue 10 Year - 151.79 % -38.45 %
EBIT Growth 163.42 % 160.62 % -167.63 %
Net Income Growth 102.29 % -25.08 % -193.2 %
Net Income 3 Yeari Growth Per Share 100.04 % -54.31 % -482.97 %
Net Income 5 Yeari Growth Per Share 100.01 % 136.64 % -58.26 %
Net Income 10 Yeari Growth Per Share 100.29 % 172.34 % -140.46 %
Operating Income Growth 110.65 % 60.03 % -169.98 %
Operating Cash Flow Growth (CFG) 123.36 % 47.58 % -8.85 %
Operating 3 Year CFG 105.68 % -8.32 % 52.26 %
Operating 5 Year CFG 100.84 % 53.11 % 123.59 %
Operating 10 Year CFG 108.46 % 465.93 % -81.66 %
EPS Growth 102.27 % -25.78 % -190 %
EPS Diluted Growth 102.23 % -26.25 % -190 %
Book Value Per Share -5.55 % -7.08 % -30.36 %
Share Holder 3 Year Equity Growth Per Share -66.44 % 18.85 % -49 %
Share Holder 5 Year Equity Growth Per Share -95.28 % 42.42 % -62.86 %
Share Holder 10 Year Equity Growth Per Share 160.08 % 217.07 % -82.6 %
Dividend Per Share Growth - 2.65 % -
Dividend 3 Year Growth Per Share - 3.86 % -
Dividend 5 Year Growth Per Share - 3.84 % -100 %
Dividend 10 Year Growth Per Share - 108.67 % -100 %
Debt Growth -0.2 % 4.59 % -10.29 %
Free Cash Flow Growth 96.66 % 263.47 % -11.05 %
Updated On 31 Mar 2025 31 Mar 2025 31 Dec 2024
Profitability
ACB ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 54.65 % 70.03 % 60.54 % 61.52 % 49.6 % 98.49 %
Return on Assets TTM 0.19 % 18.04 % 0.98 % 4.2 % -0.39 % 8.95 %
Return on Equity TTM 0.28 % 53.21 % 1.95 % 8.74 % -2.58 % 13.22 %
Return on Capital Employed TTM 0.67 % 31.67 % 3.43 % 7.74 % 3.16 % 14.8 %
Net Income Per EBT TTM 7.81 % 78.72 % 72.1 % 75.5 % 222.54 % 66.08 %
EBT Per Ebit TTM 411.92 % 94.26 % 46.84 % 86.58 % -7.94 % 106.48 %
EBIT Per Revenue TTM 1.44 % 37.51 % 9.05 % 19.64 % 5.38 % 19.72 %
Cash Flow To Debt Ratio TTM 15.3 % 43.13 % 23.79 % - 7.93 % 129.2 %
Receivables Turnover TTM 8.08 6.09 6.59 5.9 4.67 4.21
Payables Turnover TTM 5.64 5.54 4.53 2.19 3.35 0.36
Inventory Turnover TTM 0.65 1.15 1.54 3.63 2.4 0.66
Fixed Asset Turnover TTM 128.04 % 244.46 % 229.02 % 584.75 % 321.73 % 429.78 %
Asset Turnover TTM 40.26 % 64.82 % 31.99 % 32.73 % 41.43 % 64.53 %
Operating Cash Flow Per Share TTM 0.29 6.58 684.97 - 1.21 5.73
Free Cash Flow Per Share TTM -0.05 4.99 531.34 - 0.78 5.34
Cash Per Share TTM 252.34 % 322.4 % 26788.97 % 24.05 % 188.4 % 985.45 %
Operating Cash Flow Sales Ratio TTM 4.66 % 31.21 % 23.92 % - 8.36 % 22.6 %
Free Cash Flow Operating Cash Flow Ratio TTM -17.83 % 75.76 % 77.57 % - 64.03 % 93.2 %
Cash Flow Coverage Ratios TTM 15.3 % 43.13 % 23.79 % - 7.93 % 129.2 %
Price To Free Cash Flows Ratio TTM -132.76 30.6 8.44 - 25.45 27.05
Price To Operating Cash Flows Ratio TTM 23.09 23.28 6.56 - 16.3 25.16
Price Cash Flow Ratio TTM 23.09 23.28 6.56 - 16.3 25.16
Income Statement (TTM)
ACB ZTS TAK HLN TEVA NBIX
Revenue $0.34B $9.26B $4581.55B $11.23B $16.54B $2.36B
Gross Profit $0.19B $6.4B $3001.33B $6.95B $8.06B $2.32B
Gross Profit Ratio 54.65% 69.1% 65.51% 61.85% 48.74% 98.56%
EBITDA $0.05B $3.87B $1210.51B $2.51B $0.78B $0.64B
Net Income $0B $2.49B $107.93B $1.44B $-1.64B $0.34B
EPS Diluted 0.03 5.47 33.62 0.32 -1.45 3.29
Balance Sheet (MRQ)
ACB ZTS TAK HLN TEVA NBIX
Long Term Debt $0.08B $5.39B $4517.23B $8.54B $16.3B $0.46B
Total Liabilities $0.24B $9.47B $7312.37B $18.09B $33.61B $1.13B
Total Equity $0.61B $4.77B $6935.98B $16.22B $5.72B $2.59B
Total Investments $0B $0B $10.8B $0.08B $0B $1.71B
Total Debt $0.1B $6.74B $5066.17B $10.1B $18.08B $0.46B
Total Assets $0.85B $14.24B $14248.34B $34.32B $39.33B $3.72B
Cash Flow Statement (TTM)
ACB ZTS TAK HLN TEVA NBIX
Net Income $0.02B $2.5B $107.93B $1.44B $-1.96B $0.34B
Inventory $-0.02B $-0.04B $-34.97B $0.22B $0.17B $-0.02B
Dividends Paid $0B $-0.79B $-302.5B $-0.57B $0B $0B
Operating Cash Flow $0.02B $2.95B $1057.18B $2.3B $1.25B $0.6B
Capital Expenditure $-0.02B $-0.66B $-200.8B $-0.25B $-0.5B $-0.04B
Related Stocks
Ticker Name Price
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 3.4791
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 8.1
ALVOW Alvotech 1
AMPH Amphastar Pharmaceuticals, Inc. 27.445
AMRX Amneal Pharmaceuticals, Inc. 9.83
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 97.78
APUS Apimeds Pharmaceuticals US, Inc 2.039
AQST Aquestive Therapeutics, Inc. 5.025
ASRT Assertio Holdings, Inc. 0.8101
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 15.1441
AYTU Aytu BioPharma, Inc. 2.39
ETFs With Exposure to ACB
Ticker ETF Name Weight Percentage Price
MJ ETFMG Alternative Harvest ETF 3.91 30.97
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 87.925
PDN Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.015 41.925
XCS.TO iShares S&P/TSX Small Cap Index ETF 0.12159 26.89
VALT ETFMG Sit Ultra Short ETF 3.29 48.52
THCX The Cannabis ETF 3.84 16.5963
POTX Global X Cannabis ETF 1.13 5.15
TOKE Cambria Cannabis ETF 2.27 6.01
YOLO AdvisorShares Pure Cannabis ETF 2.33 3.04
DFAI Dimensional International Core Equity Market ETF 0.000538 36.525
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 2.79 1.75
BAD B.A.D. ETF 2.16 11.91
DFIC Dimensional International Core Equity 2 ETF 0.000345 33.005
DFIS Dimensional International Small Cap ETF 0.002271 31.75
DFSI Dimensional International Sustainability Core 1 ETF 0 41.285
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.00185 7.468
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0 31.545
CBUG.DE iShares MSCI World Small Cap ESG Enhanced UCITS ETF 0.00038 5.032
DXIV Dimensional ETF Trust 0.00085629 61.5574
Unlock